Glutamate carboxypeptidase 2 market is anticipated to grow at a significant CAGR during the forecast period. Glutamate Carboxypeptidase 2 is an enzyme that is encoded by the FOLH1 (folate hydrolase 1) gene in humans and is a class 2 membrane glycoprotein. It is used for the diagnosis and treatment of prostate cancer, and neurological disorder, among others. The major factor contributing to the growth of the market is the increasing prevalence of prostate cancer across the globe.
According to the American Cancer Society, in 2022, there will be an estimated 268,490 new cases of prostate cancer with a mortality rate of 34,500. Additionally, approximately 1 man in 8 is diagnosed with prostate cancer during his lifetime and it is more likely to develop in older men and non-Hispanic black men. Furthermore, approximately 6 cases in 10 are diagnosed in men of age 65 years or older. However, it is rare in men under 40 and the average age of men at diagnosis is about 66. Hence, the increasing prevalence of prostate cancer is driving the demand for GCP 2 treatment, which in turn, is driving the market growth. Furthermore, the market is growing due to new FDA approvals. For instance, in September 2021, Martin Pomper, M.D., PhD, a professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science, received the US Food and Drug Administration’s approval for positron emission tomography (PET) imaging agent targeting the prostate-specific membrane antigen (PSMA).
To Request a Sample of our Report on Glutamate Carboxypeptidase 2 Market: https://www.omrglobal.com/request-sample/glutamate-carboxypeptidase-2-market
Market Coverage
- The market number available for – 2021-2029
- Base year- 2021
- Forecast period- 2023-2029
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape– Eisai Co Ltd, and Inovio Pharmaceuticals Inc., among others.
A full Report of Glutamate Carboxypeptidase 2 Market is Available @ https://www.omrglobal.com/industry-reports/glutamate-carboxypeptidase-2-market
Glutamate Carboxypeptidase 2 Market Report by Segment
By Type
- INO-5150
- E-2072
- Others
By Application
- Prostate Cancer
- Neuropathic Pain
- Congnitive Impairment
- Glioblastoma Multiforme
- Others
Glutamate Carboxypeptidase 2 Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
